Skip Navigation


Annals of Oncology Advance Access originally published online on December 10, 2008
Annals of Oncology 2009 20(3):556-563; doi:10.1093/annonc/mdn642
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/3/556    most recent
mdn642v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mousavi, S. M.
Right arrow Articles by Seddighi, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mousavi, S. M.
Right arrow Articles by Seddighi, Z.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

epidemiology

Cancer incidence and mortality in Iran

S. M. Mousavi1,2,3,*, M. M. Gouya3, R. Ramazani3, M. Davanlou3, N. Hajsadeghi3 and Z. Seddighi3

1 Department of Community Medicine, Faculty of Medicine, Liver and Gastro Intestinal Diseases Research Center, Tabriz University of Medical Science, Tabriz
2 Cancer Research Center of Cancer Institute, Tehran University of Medical Science
3 Center for Disease Control and Prevention, Ministry of Health and Medical Education, Tehran, Iran

* Correspondence to: S. M. Mousavi, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Science, Golgasht Avenue, 5166614766 Tabriz, Iran. Tel/Fax: +98-411-3364668; Email: smmousavi{at}yahoo.com

Background: Cancer is the third main cause of death in Iran. This report was provided for explaining cancer incidence and mortality.

Patients and methods: The National Cancer Registry reports from 2003 to 2006, population-based cancer registry reports from five provinces in 2006 and National Death Registry reports from 1999 to 2004 have been applied in this report.

Results: The age-standardized incidence rate of cancers was 98 and 110 per 100 000 among females and males. The male to female standard ratio was 1.12. The most common cancer among women and men was breast cancer (24) and stomach cancer (15), respectively. The estimated mortality rate for cancer was 41.1 and 65 per 100 000 for females and males in 2004.

Conclusion: The current low cancer incidence rates in Iran might be due to lack of national cancer screening programs for prostate, colorectal or breast cancer, a consequence of incomplete registration as well as incomplete diagnosis of cancer patients; it is expected that it will rise dramatically in the future because of anticipated increase in life expectancy and westernized lifestyle. The first priorities for health policy makers should be developing, establishing and implementing national cancer control; or else, the health system could not respond to the demands regarding to diagnosis, treatment and palliation for these patients in the future.

Key words: cancer, incidence, Iran, mortality

Received for publication August 22, 2008. Accepted for publication August 25, 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.